FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gavin Giovannoni

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Physiology

Disease Progression

Anatomy

Procedures

Enzyme-Linked Immunosorbent Assay

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Ruth Dobson; Gavin Giovannoni
Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis.
Ruth Dobson; Alastair John Noyce; Alison Yarnall; Gavin Giovannoni
Bone health in chronic neurological diseases: a focus on Multiple sclerosis and Parkinsonian syndromes.
Ruth Dobson; Sreeram V Ramagopalan; Gavin Giovannoni
Genome-wide association studies: will we ever predict susceptibility to multiple sclerosis through genetics?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gavin Giovannoni (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ruth Dobson; Gavin Giovannoni
Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis.
Journal of neurology 2013;260(5):1272-85.
2013: Ruth Dobson; Alastair John Noyce; Alison Yarnall; Gavin Giovannoni
Bone health in chronic neurological diseases: a focus on Multiple sclerosis and Parkinsonian syndromes.
Practical neurology 2013;13(2):70-9.
2013: Ruth Dobson; Sreeram V Ramagopalan; Gavin Giovannoni
Genome-wide association studies: will we ever predict susceptibility to multiple sclerosis through genetics?
Expert review of neurotherapeutics 2013;13(3):235-7.
2013: Ruth Dobson; Sunay Gangadharan; Sara Geraldine Leddy; Gavin Giovannoni
Assessing fracture risk in people with MS: a service development study comparing three fracture risk scoring systems.
BMJ open 2013;3(3):.
2013: Alan J Thompson; Gavin Giovannoni
Removal of access to alemtuzumab for patients with aggressive multiple sclerosis.
BMJ (Clinical research ed.) 2013;346():f275.
2013: Tizong Miao; Meera Raymond; Alistair L J Symonds; Punamdip Bhullar; Emma Ghaffari; Gavin Giovannoni; Suling Li; Ute C Meier; Ping Wang
Early growth response gene-2 controls IL-17 expression and Th17 differentiation by negatively regulating Batf.
Journal of immunology (Baltimore, Md. : 1950) 2013;190(1):58-65.
2013: Ruth Dobson; Joanne Topping; Gavin Giovannoni
Comparison of two commercial ELISA systems for evaluating anti-EBNA1 IgG titers.
Journal of medical virology 2013;85(1):128-31.
2012: Alastair J Noyce; Laura Silveira-Moriyama; Jonathan P Bestwick; Gavin Giovannoni; Christopher H Hawkes; Andrew J Lees; Anette Schrag
Meta-analysis of early nonmotor features and risk factors for Parkinson disease.
Annals of neurology 2012;72(6):893-901.
2012: Jeffrey A Cohen; Alasdair J Coles; D Alastair S Compston; Christian Confavreux; Bella I Ertik; Elizabeth Fisher; Edward J Fox; Gavin Giovannoni; Hans-Peter Hartung; Eva Havrdova; Stephen L Lake; David H Margolin; Michael A Panzara; Krzysztof W Selmaj; Miroslav Stojanovic; Howard L Weiner; Douglas L Arnold; Vesna V Brinar
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.
Lancet 2012;380(9856):1819-28.
2012: Huriya Beyan; Bernhard O Boehm; Corrado M Cilio; Thomas A Down; George C Ebers; Carolina Gemma; Gavin Giovannoni; Michelle L Holland; R David Leslie; Anita Nilsson; Sreeram V Ramagopalan; Kristina Uvebrant; Ake Lernmark; Vardhman K Rakyan
Guthrie card methylomics identifies temporally stable epialleles that are present at birth in humans.
Genome research 2012;22(11):2138-45.
2012: Ruth Dobson; Sreeram Ramagopalan; Gavin Giovannoni
Bone health and multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2012;18(11):1522-8.
2012: Arie R Gafson; Gavin Giovannoni
Towards the incorporation of lumbar puncture into clinical trials for multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2012;18(10):1509-11.
2012: Joel B Raffel; Joanne Topping; John Bremner; Kevin E Brown; David Hunt; Gavin Giovannoni
Assay selection affects John Cunningham virus serostatus classification in multiple sclerosis.
Annals of neurology 2012;72(2):295-6; author reply 296-7.
2012: Gavin Giovannoni; E Southam; E Waubant
Systematic review of disease-modifying therapies to assess unmet needs in multiple sclerosis: tolerability and adherence.
Multiple sclerosis (Houndmills, Basingstoke, England) 2012;18(7):932-46.
2012: Sharmilee Gnanapavan; Donna Grant; Sam Jackson; Gareth Pryce; David Baker; Gavin Giovannoni
Neurofilament a biomarker of neurodegeneration in autoimmune encephalomyelitis.
Autoimmunity 2012;45(4):298-303.
2012: Bianca Weinstock-Guttman; Steven L Galetta; Gavin Giovannoni; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Frances Lynn; Paul W O'Connor; J Theodore Phillips; Chris Polman; William H Stuart; Christophe Hotermans
Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS.
Journal of neurology 2012;259(5):898-905.
2012: Ruth Dobson; Sreeram Ramagopalan; Gavin Giovannoni
The effect of gender in clinically isolated syndrome (CIS): a meta-analysis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2012;18(5):600-4.
2012: Rachel A Farrell; Adriana J Gaeguta; Gavin Giovannoni; Monica Marta; Veronika Souslova; Paul I Creeke
Development of resistance to biologic therapies with reference to IFN-β.
Rheumatology (Oxford, England) 2012;51(4):590-9.
2012: Douglas Kazutoshi Sato; Yuko Shimizu; Yuji Tomizawa; Kazumasa Yokoyama; Paul I Creeke; Rachel Farrell; Kazuo Fujihara; Toshiyuki Fukazawa; Gavin Giovannoni; Yasuto Itoyama; Tatsuro Misu; Ichiro Nakashima; Masashi Aoki
Neutralizing antibodies are associated with a reduction of interferon-β efficacy during the treatment of Japanese multiple sclerosis patients.
The Tohoku journal of experimental medicine 2012;228(2):85-92.
2012: Alastair J Noyce; Connor Treacy; Caroline Budu; Julian Fearnley; Andrew J Lees; Gavin Giovannoni
The new Bradykinesia Akinesia Incoordination (BRAIN) test: preliminary data from an online test of upper limb movement.
Movement disorders : official journal of the Movement Disorder Society 2012;27(1):157-8.
2011: R A Farrell; P I Creeke; M Espasandin; N Lakdawala; V Worthington; Gavin Giovannoni
Incorporation of an interferon-β neutralizing antibody assay into routine clinical practice.
Multiple sclerosis (Houndmills, Basingstoke, England) 2011;17(11):1333-40.
2011: Shahrzad Hadavi; R David Leslie; Alastair J Noyce; Gavin Giovannoni
Stiff person syndrome.
Practical neurology 2011;11(5):272-82.
2011: Sharmilee Gnanapavan; Angela Vincent; Gavin Giovannoni
Surviving stiff-person syndrome: a case report.
Journal of neurology 2011;258(10):1898-900.
2011: H Maruszak; B J Brew; Gavin Giovannoni; J Gold
Could antiretroviral drugs be effective in multiple sclerosis? A case report.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2011;18(9):e110-1.
2011: Sarah Al-Izki; Gavin Giovannoni; Samuel J Jackson; Gareth Pryce; David Baker
Immunosuppression with FTY720 is insufficient to prevent secondary progressive neurodegeneration in experimental autoimmune encephalomyelitis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2011;17(8):939-48.
2011: Samuel J Jackson; Gavin Giovannoni; David Baker
Fingolimod modulates microglial activation to augment markers of remyelination.
Journal of neuroinflammation 2011;8():76.
2010: Axel Petzold; Tjeerd Mondria; Jens Kuhle; Maria A Rocca; Jan Cornelissen; Peter te Boekhorst; Bob Lowenberg; Gavin Giovannoni; Massimo Filippi; Ludwig Kappos; Rogier Q Hintzen
Evidence for acute neurotoxicity after chemotherapy.
Annals of neurology 2010;68(6):806-15.
2010: Rachel A Farrell; Gavin Giovannoni
Current and future role of interferon beta in the therapy of multiple sclerosis.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2010;30(10):715-26.
2010: Zhaleh Khaleeli; Daniel G Healy; Anthony Briddon; Michael P Lunn; Mary M Reilly; John Land; Gavin Giovannoni
[Copper deficiency as a treatable cause of poor balance].
Praxis 2010;99(19):1153-6.
2010: Sharmilee Gnanapavan; Donna Grant; Eva Illes-Toth; Neghat Lakdawala; Geoff Keir; Gavin Giovannoni
Neural cell adhesion molecule--description of a CSF ELISA method and evidence of reduced levels in selected neurological disorders.
Journal of neuroimmunology 2010;225(1-2):118-22.
2010: Chris H Polman; Antonio Bertolotto; Florian Deisenhammer; Gavin Giovannoni; Hans-Peter Hartung; Bernhard Hemmer; Joep Killestein; Henry McFarland; Joel Oger; Andrew R Pachner; John Petkau; Anthony T Reder; Stephen C Reingold; Huub Schellekens; Per Soelberg Sørensen
Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis.
Lancet neurology 2010;9(7):740-50.
2010: Laura A N Peferoen; Floris Lamers; Lenthe N R Lodder; Wouter Gerritsen; Inge Huitinga; Jeroen Melief; Gavin Giovannoni; Ute Meier; Rogier Q Hintzen; Georges M G M Verjans; Gijsbert P van Nierop; Wim Vos; Regina M B Peferoen-Baert; Jaap Middeldorp; Paul Van Der Valk; Sandra Amor
Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis.
Brain : a journal of neurology 2010;133(Pt 5):e137.
2010: Charlotte E Teunissen; H T Tumani; J L Bennett; F S Berven; L Brundin; M Comabella; D Franciotta; J L Federiksen; J O Fleming; R Furlan; Rogier Q Hintzen; Steven Hughes; M H Johnson; E Krasulova; J Kuhle; Maria Chiara Magnone; Axel Petzold; C Rajda; K Rejdak; H K Schmidt; V van Pesch; E Waubant; Christian Wolf; B Hemmer; F Deisenhammer; Gavin Giovannoni
Short commentary on 'a consensus protocol for the standardization of cerebrospinal fluid collection and biobanking'.
Multiple sclerosis (Houndmills, Basingstoke, England) 2010;16(2):129-32.
2010: Zhaleh Khaleeli; Daniel G Healy; Anthony Briddon; Michael P Lunn; Mary M Reilly; John Land; Gavin Giovannoni
Copper deficiency as a treatable cause of poor balance.
BMJ (Clinical research ed.) 2010;340():c508.
2009: Charlotte E Teunissen; Axel Petzold; J L Bennett; F S Berven; L Brundin; M Comabella; D Franciotta; J L Frederiksen; J O Fleming; R Furlan; R Q Hintzen; Steven Hughes; M H Johnson; E Krasulova; J Kuhle; M C Magnone; C Rajda; K Rejdak; H K Schmidt; V van Pesch; E Waubant; Christian Wolf; Gavin Giovannoni; B Hemmer; H Tumani; F Deisenhammer
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.
Neurology 2009;73(22):1914-22.
2009: Anette Schrag; Ruth Gilbert; Gavin Giovannoni; Mary M Robertson; C Metcalfe; Y Ben-Shlomo
Streptococcal infection, Tourette syndrome, and OCD: is there a connection?
Neurology 2009;73(16):1256-63.
2009: R A Farrell; D Antony; G R Wall; D A Clark; L Fisniku; Josephine K Swanton; Zhaleh Khaleeli; Klaus Schmierer; David H Miller; Gavin Giovannoni
Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
Neurology 2009;73(1):32-8.
2009: Connie Luk; Gavin Giovannoni; David R Williams; Andrew J Lees; Rohan de Silva
Development of a sensitive ELISA for quantification of three- and four-repeat tau isoforms in tauopathies.
Journal of neuroscience methods 2009;180(1):34-42.
2009: Michael Hutchinson; Ludwig Kappos; Peter A Calabresi; Christian Confavreux; Gavin Giovannoni; Steven L Galetta; Eva Havrdova; Fred D Lublin; David H Miller; Paul W O'Connor; J Theodore Phillips; Chris H Polman; Ernst-Wilhelm Radue; Richard A Rudick; William H Stuart; Andrzej Wajgt; Bianca Weinstock-Guttman; Daniel Wynn; Frances Lynn; Michael A Panzara
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL.
Journal of neurology 2009;256(3):405-15.
2009: Eva Havrdova; Steven Galetta; Michael Hutchinson; Dusan Stefoski; David Bates; Chris H Polman; Paul W O'Connor; Gavin Giovannoni; J Theodore Phillips; Fred D Lublin; Amy Pace; Richard Kim; Robert Hyde
Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study.
Lancet neurology 2009;8(3):254-60.
2008: Bart P C van de Warrenburg; Andrew J Church; Davide Martino; Paul M Candler; Kailash P Bhatia; Gavin Giovannoni; Niall Quinn
Antineuronal antibodies in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2008;23(7):958-63.
2008: R Farrell; Raju Kapoor; S Leary; Peter Rudge; Aj Thompson; Dh Miller; Gavin Giovannoni
Neutralizing anti-interferon beta antibodies are associated with reduced side effects and delayed impact on efficacy of Interferon-beta.
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(2):212-8.
2008: Rachel Farrell; Klaus Bendtzen; Antonio Bertolotto; Berwyn Clark; Manuel Comabella; Florian Deisenhammer; Anna Fogdell-Hahn; Gavin Giovannoni; Hans Peter Hartung; Bernard Hemmer; Jan Hillert; Ludwig Kappos; Joep Killestein; Raija Lindberg; Xavier Montalban; Chris Polman; Per Soelberg Sorensen
Re: Neutralizing antibodies to interferon beta-1b are not associated with disease worsening in multiple sclerosis.
The Journal of international medical research 2008;36(1):204-8; author reply 208-10.
2008: J. Ludovic Croxford; Gareth Pryce; Samuel J Jackson; Catherine Ledent; Gavin Giovannoni; Roger G Pertwee; Takashi Yamamura; David Baker
Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis.
Journal of neuroimmunology 2008;193(1-2):120-9.
2007: Chris H Polman; Florian Deisenhammer; Gavin Giovannoni; Joep Killestein; Huub Schellekens
Re: Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Neurology 2007;69(15):1553-4; author reply 1555.
2007: Peter A Calabresi; Gavin Giovannoni; Christian Confavreux; Steven L Galetta; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; David H Miller; Paul W O'Connor; J Theodore Phillips; Chris H Polman; Ernst-Wilhelm Radue; Richard A Rudick; William H Stuart; Fred D Lublin; Andrzej Wajgt; Bianca Weinstock-Guttman; Daniel R Wynn; Frances Lynn; Michael A Panzara
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL.
Neurology 2007;69(14):1391-403.
2007: Richard A Rudick; Deborah Miller; Steve Hass; Michael Hutchinson; Peter A Calabresi; Christian Confavreux; Steven L Galetta; Gavin Giovannoni; Eva Havrdova; Ludwig Kappos; Fred D Lublin; David H Miller; Paul W O'Connor; J Theodore Phillips; Chris H Polman; Ernst-Wilhelm Radue; William H Stuart; Andrzej Wajgt; Bianca Weinstock-Guttman; Daniel R Wynn; Frances Lynn; Michael A Panzara
Health-related quality of life in multiple sclerosis: effects of natalizumab.
Annals of neurology 2007;62(4):335-46.
2007: Davide Martino; Giovanni Defazio; Andrew J Church; Russell C Dale; Gavin Giovannoni; Mary M Robertson; Michael Orth
Antineuronal antibody status and phenotype analysis in Tourette's syndrome.
Movement disorders : official journal of the Movement Disorder Society 2007;22(10):1424-9.
2007: Hans-P Hartung; Chris H Polman; Antonio Bertolotto; Florian Deisenhammer; Gavin Giovannoni; Eva Havrdova; Bernhard Hemmer; Jan Hillert; Ludwig Kappos; Bernd C Kieseier; Joep Killestein; Christophe Malcus; Manuel Comabella; Andrew R Pachner; Huub Schellekens; Finn Sellebjerg; Krzysztof Selmaj; Per Soelberg Sorensen
Neutralising antibodies to interferon beta in multiple sclerosis : expert panel report.
Journal of neurology 2007;254(7):827-37.
2007: Charlotte E Teunissen; Joep Killestein; Gavin Giovannoni
Biomarker research in multiple sclerosis: addressing axonal damage and heterogeneity.
Biomarkers in medicine 2007;1(1):111-9.
2007: Rachel A Farrell; Gavin Giovannoni
Measuring and management of anti-interferon beta antibodies in subjects with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2007;13(5):567-77.
2007: David H Miller; Derek Soon; Kryshani T M Fernando; David G MacManus; Gareth Barker; Tarek A Yousry; Elizabeth Fisher; Paul W O'Connor; J Theodore Phillips; Chris H Polman; Ludwig Kappos; Michael Hutchinson; Eva Havrdova; Fred D Lublin; Gavin Giovannoni; Andrzej Wajgt; Richard A Rudick; Frances Lynn; Michael A Panzara; Alfred W Sandrock
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS.
Neurology 2007;68(17):1390-401.
2007: Laura J Balcer; Steven L Galetta; Peter A Calabresi; Christian Confavreux; Gavin Giovannoni; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; David H Miller; Paul W O'Connor; J Theodore Phillips; Chris H Polman; Ernst-Wilhelm Radue; Richard A Rudick; William H Stuart; Andrzej Wajgt; Bianca Weinstock-Guttman; Daniel R Wynn; Frances Lynn; Michael A Panzara
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis.
Neurology 2007;68(16):1299-304.
2007: Miles D Chapman; Edward J Thompson; Paul M Candler; Russell C Dale; Andrew J Church; Gavin Giovannoni
Quantitative demonstration of intrathecal synthesis of high affinity immunoglobulin G in herpes simplex encephalitis using affinity-mediated immunoblotting.
Journal of neuroimmunology 2007;185(1-2):130-5.
2007: Derek Soon; Daniel R Altmann; Kryshani T M Fernando; Gavin Giovannoni; Frederick Barkhof; Chris H Polman; Paul O'Connor; Bruce Gray; Michael A Panzara; David H Miller
A study of subtle blood brain barrier disruption in a placebo-controlled trial of natalizumab in relapsing remitting multiple sclerosis.
Journal of neurology 2007;254(3):306-14.
2006: Konrad Rejdak; M Empl; Nicola J Giffin; Shazia K Afridi; Axel Petzold; Z Stelmasiak; Edward J Thompson; Peter J Goadsby; Holger Kaube; Gavin Giovannoni
Increased urinary excretion of nitric oxide metabolites in longitudinally monitored migraine patients.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2006;13(12):1346-51.
2006: J Theodore Phillips; Paul W O'Connor; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; David H Miller; Chris H Polman; Fred D Lublin; Gavin Giovannoni; Andrzej Wajgt; Frances Lynn; Michael A Panzara; Alfred W Sandrock
Infusion-related hypersensitivity reactions during natalizumab treatment.
Neurology 2006;67(9):1717-8.
2006: Gavin Giovannoni; Miles D Chapman; Edward J Thompson
The role of antibody affinity for specific antigens in the differential diagnosis of inflammatory nervous system disorders.
Journal of neuroimmunology 2006;180(1-2):29-32.
2006: Gavin Giovannoni; Gary R Cutter; Jan Lunemann; Roland Martin; Christian Münz; Subramaniam Sriram; Israel Steiner; Margaret R Hammerschlag; Charlotte A Gaydos
Infectious causes of multiple sclerosis.
Lancet neurology 2006;5(10):887-94.
2006: Virginija Danylaité Karrenbauer; Valerio Leoni; Ee Tuan Lim; Gavin Giovannoni; Gordon T Ingle; Jaume Sastre-Garriga; Alan J Thompson; Waqar Rashid; Gerard Davies; David H Miller; Ingemar Björkhem; Thomas Masterman
Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis.
Clinical neurology and neurosurgery 2006;108(5):456-60.
2006: Axel Petzold; M I Eikelenboom; Geoff Keir; Chris H Polman; Bernard Uitdehaag; Edward J Thompson; Gavin Giovannoni
The new global multiple sclerosis severity score (MSSS) correlates with axonal but not glial biomarkers.
Multiple sclerosis (Houndmills, Basingstoke, England) 2006;12(3):325-8.
2006: Russell C Dale; Andrew J Church; Paul M Candler; M Chapman; Davide Martino; Gavin Giovannoni
Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls.
Neurology 2006;66(10):1612; author reply 1612.
2006: Paul M Candler; Russell C Dale; S Griffin; Andrew J Church; Robin Wait; Miles D Chapman; Geoff Keir; Gavin Giovannoni; Jeremy H Rees
Post-streptococcal opsoclonus-myoclonus syndrome associated with anti-neuroleukin antibodies.
Journal of neurology, neurosurgery, and psychiatry 2006;77(4):507-12.
2006: Chris H Polman; Paul W O'Connor; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; David H Miller; J Theodore Phillips; Fred D Lublin; Gavin Giovannoni; Andrzej Wajgt; Martin Toal; Frances Lynn; Michael A Panzara; Alfred W Sandrock
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.
The New England journal of medicine 2006;354(9):899-910.
2006: Russell C Dale; Paul M Candler; Andrew J Church; Robin Wait; Jennifer Pocock; Gavin Giovannoni
Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease.
Journal of neuroimmunology 2006;172(1-2):187-97.
2006: Gavin Giovannoni
Multiple sclerosis cerebrospinal fluid biomarkers.
Disease markers 2006;22(4):187-96.
2006: Gavin Giovannoni
PANDAS: overview of the hypothesis.
Advances in neurology 2006;99():159-65.
2005: Rachel Farrell; Dominic Heaney; Gavin Giovannoni
Emerging therapies in multiple sclerosis.
Expert opinion on emerging drugs 2005;10(4):797-816.
2005: Davide Martino; Joceline A Branson; Andrew J Church; Paul M Candler; Paolo Livrea; Gavin Giovannoni; Russell C Dale
Soluble adhesion molecules in acute disseminated encephalomyelitis.
Pediatric neurology 2005;33(4):255-8.
2005: Ee Tuan Lim; Finn Sellebjerg; CV Jensen; Daniel R Altmann; D Grant; Geoff Keir; Edward J Thompson; Gavin Giovannoni
Acute axonal damage predicts clinical outcome in patients with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2005;11(5):532-6.
2005: Ee Tuan Lim; T Berger; M Reindl; Catherine M Dalton; Kryshani T M Fernando; Geoff Keir; Edward J Thompson; David H Miller; Gavin Giovannoni
Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2005;11(4):492-4.
2005: Gareth Pryce; Janet K O'Neill; J. Ludovic Croxford; Sandra Amor; Deborah J R Hankey; Emma East; Gavin Giovannoni; David Baker
Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis.
Journal of neuroimmunology 2005;165(1-2):41-52.
2005: Davide Martino; Andrew J Church; Giovanni Defazio; Russell C Dale; Niall Quinn; Mary M Robertson; P Livrea; Michael Orth; Gavin Giovannoni
Soluble adhesion molecules in Gilles de la Tourette's syndrome.
Journal of the neurological sciences 2005;234(1-2):79-85.
2005: Ee Tuan Lim; Gavin Giovannoni
Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.
Expert review of neurotherapeutics 2005;5(3):379-90.
2005: Davide Martino; A Tanner; Giovanni Defazio; Andrew J Church; K P Bhatia; Gavin Giovannoni; Russell C Dale
Tracing Sydenham's chorea: historical documents from a British paediatric hospital.
Archives of disease in childhood 2005;90(5):507-11.
2005: Axel Petzold; M Judith Eikelenboom; Geoff Keir; D Grant; R H C Lazeron; Chris H Polman; Bernard Uitdehaag; Edward J Thompson; Gavin Giovannoni
Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study.
Journal of neurology, neurosurgery, and psychiatry 2005;76(2):206-11.
2005: Davide Martino; Gavin Giovannoni
Autoaggressive immune-mediated movement disorders.
Advances in neurology 2005;96():320-35.
2005: Miles D Chapman; JC Hartley; SJ Furrows; G L Ridgeway; Edward J Thompson; Andrew J Church; Paul M Candler; Gavin Giovannoni
Lack of serum oligoclonal antibody responses to Chlamydophila pneumoniae in multiple sclerosis.
European neurology 2005;53(2):81-3.
2005: Miles D Chapman; Lucy E Hughes; Clyde D Wilson; Simon Namnyak; Edward J Thompson; Gavin Giovannoni
No evidence for production of intrathecal immunoglobulin G against Acinetobacter or Pseudomonas in multiple sclerosis.
European neurology 2005;53(1):27-31.
2004: Konrad Rejdak; M Judith Eikelenboom; Axel Petzold; Edward J Thompson; Z Stelmasiak; R H C Lazeron; Frederik Barkhof; Chris H Polman; Bernard Uitdehaag; Gavin Giovannoni
CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis.
Neurology 2004;63(8):1439-45.
2004: Mark J Edwards; Russell C Dale; Andrew J Church; Eleni Trikouli; Niall Quinn; Andrew J Lees; Gavin Giovannoni; Kailash P Bhatia
Adult-onset tic disorder, motor stereotypies, and behavioural disturbance associated with antibasal ganglia antibodies.
Movement disorders : official journal of the Movement Disorder Society 2004;19(10):1190-6.
2004: Gavin Giovannoni
Optimising MS disease-modifying therapies: antibodies in perspective.
Journal of neurology 2004;251 Suppl 5():v30-v35.
2004: Davide Martino; Gavin Giovannoni
Antibasal ganglia antibodies and their relevance to movement disorders.
Current opinion in neurology 2004;17(4):425-32.
2004: M J Edwards; E Trikouli; Davide Martino; Maria Bozi; Russell C Dale; Andrew J Church; Anette Schrag; Andrew J Lees; Niall Quinn; Gavin Giovannoni; Kailash P Bhatia
Anti-basal ganglia antibodies in patients with atypical dystonia and tics: a prospective study.
Neurology 2004;63(1):156-8.
2004: Andrew J Church; Russell C Dale; Gavin Giovannoni
Anti-basal ganglia antibodies: a possible diagnostic utility in idiopathic movement disorders?
Archives of disease in childhood 2004;89(7):611-4.
2004: Axel Petzold; David Brassat; P Mas; Konrad Rejdak; Geoff Keir; Gavin Giovannoni; Edward J Thompson; Michel Clanet
Treatment response in relation to inflammatory and axonal surrogate marker in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(3):281-3.
2004: Ee Tuan Lim; D Grant; Mikhail Pashenkov; Geoff Keir; Edward J Thompson; Mats Söderström; Gavin Giovannoni
Cerebrospinal fluid levels of brain specific proteins in optic neuritis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(3):261-5.
2004: Mark J Edwards; Russell C Dale; Andrew J Church; Gavin Giovannoni; Kailash P Bhatia
A dystonic syndrome associated with anti-basal ganglia antibodies.
Journal of neurology, neurosurgery, and psychiatry 2004;75(6):914-6.
2004: Konrad Rejdak; Axel Petzold; Martyn A Sharpe; Andrew D Kay; Mary Kerr; Geoff Keir; Edward J Thompson; Gavin Giovannoni
Cerebrospinal fluid nitrite/nitrate correlated with oxyhemoglobin and outcome in patients with subarachnoid hemorrhage.
Journal of the neurological sciences 2004;219(1-2):71-6.
2004: Axel Petzold; Geoff Keir; A J E Green; Gavin Giovannoni; Edward J Thompson
An ELISA for glial fibrillary acidic protein.
Journal of immunological methods 2004;287(1-2):169-77.
2004: Anthony C Pereira; Mark J Edwards; Philip C Buttery; Christopher Hawkes; Niall Quinn; Gavin Giovannoni; Marios Hadjivassiliou; Kailash P Bhatia
Choreic syndrome and coeliac disease: a hitherto unrecognised association.
Movement disorders : official journal of the Movement Disorder Society 2004;19(4):478-82.
2004: Ee Tuan Lim; Axel Petzold; Siobhan M Leary; Daniel R Altmann; Geoff Keir; Edward J Thompson; David H Miller; Alan J Thompson; Gavin Giovannoni
Serum S100B in primary progressive multiple sclerosis patients treated with interferon-beta-1a.
Journal of negative results in biomedicine 2004;3():4.
2004: Gavin Giovannoni
Management of secondary-progressive multiple sclerosis.
CNS drugs 2004;18(10):653-69.
2004: SJ Furrows; JC Hartley; J Bell; N Silver; Nick Losseff; S Stevenson; M Chapman; Edward J Thompson; Geoff L Ridgway; Gavin Giovannoni
Chlamydophila pneumoniae infection of the central nervous system in patients with multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 2004;75(1):152-4.
2003: Gavin Giovannoni
Strategies to treat and prevent the development of neutralizing anti-interferon-beta antibodies.
Neurology 2003;61(9 Suppl 5):S13-7.
2003: Gareth Pryce; Zubair Ahmed; Deborah J R Hankey; Samuel J Jackson; J. Ludovic Croxford; Jennifer Pocock; Catherine Ledent; Axel Petzold; Alan J Thompson; Gavin Giovannoni; M Louise Cuzner; David Baker
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis.
Brain : a journal of neurology 2003;126(Pt 10):2191-202.
2003: Bénédicte Dubois; Siobhan M Leary; Inge Nelissen; Ghislain Opdenakker; Gavin Giovannoni; Alan J Thompson
Serum gelatinase B/MMP-9 in primary progressive multiple sclerosis patients treated with interferon-beta-1a.
Journal of neurology 2003;250(9):1037-43.
2003: Axel Petzold; Geoff Keir; A J E Green; Gavin Giovannoni; Edward J Thompson
A specific ELISA for measuring neurofilament heavy chain phosphoforms.
Journal of immunological methods 2003;278(1-2):179-90.
2003: Bruno Dubois; E Keenan; B E Porter; Raju Kapoor; Peter Rudge; Alan J Thompson; David H Miller; Gavin Giovannoni
Interferon beta in multiple sclerosis: experience in a British specialist multiple sclerosis centre.
Journal of neurology, neurosurgery, and psychiatry 2003;74(7):946-9.
2003: David Baker; Gareth Pryce; Gavin Giovannoni; Alan J Thompson
The therapeutic potential of cannabis.
Lancet neurology 2003;2(5):291-8.
2003: Axel Petzold; David Baker; Gareth Pryce; Geoff Keir; Edward J Thompson; Gavin Giovannoni
Quantification of neurodegeneration by measurement of brain-specific proteins.
Journal of neuroimmunology 2003;138(1-2):45-8.
2003: Andrew J Church; Russell C Dale; Andrew J Lees; Gavin Giovannoni; Mary M Robertson
Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis.
Journal of neurology, neurosurgery, and psychiatry 2003;74(5):602-7.
2003: Gareth Pryce; Gavin Giovannoni; David Baker
Mifepristone or inhibition of 11beta-hydroxylase activity potentiates the sedating effects of the cannabinoid receptor-1 agonist Delta(9)-tetrahydrocannabinol in mice.
Neuroscience letters 2003;341(2):164-6.
2003: Konrad Rejdak; Axel Petzold; Martyn A Sharpe; M Smith; Geoff Keir; Z Stelmasiak; Edward J Thompson; Gavin Giovannoni
Serum and urine nitrate and nitrite are not reliable indicators of intrathecal nitric oxide production in acute brain injury.
Journal of the neurological sciences 2003;208(1-2):1-7.
2003: Gerard Davies; Geoff Keir; Edward J Thompson; Gavin Giovannoni
The clinical significance of an intrathecal monoclonal immunoglobulin band: a follow-up study.
Neurology 2003;60(7):1163-6.
2003: Andrew J Church; Russell C Dale; Francisco Cardoso; Paul M Candler; Miles D Chapman; Meredith L Allen; Nigel J Klein; Andrew J Lees; Gavin Giovannoni
CSF and serum immune parameters in Sydenham's chorea: evidence of an autoimmune syndrome?
Journal of neuroimmunology 2003;136(1-2):149-53.
2003: M Judith Eikelenboom; Axel Petzold; R H C Lazeron; E Silber; Moad K Sharief; Edward J Thompson; Frederik Barkhof; Gavin Giovannoni; Chris H Polman; Bernard Uitdehaag
Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy.
Neurology 2003;60(2):219-23.
2002: Andrew J Church; F Cardoso; Russell C Dale; Andrew J Lees; Edward J Thompson; Gavin Giovannoni
Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea.
Neurology 2002;59(2):227-31.
2002: Axel Petzold; M Judith Eikelenboom; Djordje Gveric; Geoff Keir; M Chapman; R H C Lazeron; M Louise Cuzner; Chris H Polman; Bernard Uitdehaag; Edward J Thompson; Gavin Giovannoni
Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations.
Brain : a journal of neurology 2002;125(Pt 7):1462-73.
2002: Finn Sellebjerg; Gavin Giovannoni; A Hand; HO Madsen; CV Jensen; Peter Garred
Cerebrospinal fluid levels of nitric oxide metabolites predict response to methylprednisolone treatment in multiple sclerosis and optic neuritis.
Journal of neuroimmunology 2002;125(1-2):198-203.
2002: C Derry; Russell C Dale; Maria Thom; David H Miller; Gavin Giovannoni
Unihemispheric cerebral vasculitis mimicking Rasmussen's encephalitis.
Neurology 2002;58(2):327-8.
2002: V Ramachandran; Andrew J Church; Gavin Giovannoni; Kailash P Bhatia
Anti-basal ganglia antibodies are absent in patients with primary blepharospasm.
Neurology 2002;58(1):150.
2001: Gavin Giovannoni; Alan J Thompson; David H Miller; Edward J Thompson
Fatigue is not associated with raised inflammatory markers in multiple sclerosis.
Neurology 2001;57(4):676-81.
2001: Gavin Giovannoni
Human swayback disease: expanding the spectrum of diseases associated with abnormal copper metabolism.
Journal of neurology 2001;248(8):707.
2001: V Chamoun; A Zeman; Kaj Blennow; P Fredman; Anders Wallin; Geoff Keir; Gavin Giovannoni; Edward J Thompson
Haptoglobins as markers of blood-CSF barrier dysfunction: the findings in normal CSF.
Journal of the neurological sciences 2001;182(2):117-21.
2000: Gavin Giovannoni; John D O'Sullivan; Kirsten Turner; Alice J Manson; Andrew J Lees
Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies.
Journal of neurology, neurosurgery, and psychiatry 2000;68(4):423-8.
2000: Gavin Giovannoni; NC Silver; Catriona D Good; David H Miller; Edward J Thompson
Immunological time-course of gadolinium-enhancing MRI lesions in patients with multiple sclerosis.
European neurology 2000;44(4):222-8.
1999: Gavin Giovannoni; N C Silver; J O'Riordan; R F Miller; Simon J R Heales; J M Land; M Elliot; M Feldmann; David H Miller; Edward J Thompson
Increased urinary nitric oxide metabolites in patients with multiple sclerosis correlates with early and relapsing disease.
Multiple sclerosis (Houndmills, Basingstoke, England) 1999;5(5):335-41.
1999: A J Green; Gavin Giovannoni; R F Miller; M J Harrison; E J Thompson
Cerebrospinal fluid S-100b concentrations in patients with HIV infection.
AIDS (London, England) 1999;13(1):139-40.
1998: Gavin Giovannoni; Edward J Thompson
Urinary markers of disease activity in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 1998;4(3):247-53.
1998: Gavin Giovannoni; Simon J R Heales; J M Land; Edward J Thompson
The potential role of nitric oxide in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 1998;4(3):212-6.
1998: Gavin Giovannoni; A J Green; Edward J Thompson
Are there any body fluid markers of brain atrophy in multiple sclerosis?
Multiple sclerosis (Houndmills, Basingstoke, England) 1998;4(3):138-42.
1998: Gavin Giovannoni; B Kieseier; H P Hartung
Correlating immunological and magnetic resonance imaging markers of disease activity in multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 1998;64 Suppl 1():S31-6.
1998: Gavin Giovannoni
Cerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 1998;4(1):27-30.
1998: Gavin Giovannoni; R F Miller; Simon J R Heales; John M Land; M J Harrison; Edward J Thompson
Elevated cerebrospinal fluid and serum nitrate and nitrite levels in patients with central nervous system complications of HIV-1 infection: a correlation with blood-brain-barrier dysfunction.
Journal of the neurological sciences 1998;156(1):53-8.
1997: Gavin Giovannoni
The immunopathogenesis of multiple sclerosis.
Baillière's clinical neurology 1997;6(3):387-407.
1997: Gavin Giovannoni; M Lai; J Thorpe; D Kidd; V Chamoun; Alan J Thompson; David H Miller; M Feldmann; Edward J Thompson
Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging.
Neurology 1997;48(6):1557-65.
1997: Gavin Giovannoni; Simon J R Heales; N C Silver; J O'Riordan; R F Miller; John M Land; John B Clark; Edward J Thompson
Raised serum nitrate and nitrite levels in patients with multiple sclerosis.
Journal of the neurological sciences 1997;145(1):77-81.
1997: Gavin Giovannoni; M Lai; D Kidd; J W Thorpe; David H Miller; Alan J Thompson; Geoff Keir; M Feldmann; Edward J Thompson
Daily urinary neopterin excretion as an immunological marker of disease activity in multiple sclerosis.
Brain : a journal of neurology 1997;120 ( Pt 1)():1-13.
1996: Gavin Giovannoni; A Green; G Keir; Edward J Thompson
Urinary myelin basic protein-like material as a correlate of the progression of multiple sclerosis.
Annals of neurology 1996;40(1):128-9.
1996: Gavin Giovannoni; H P Hartung
The immunopathogenesis of multiple sclerosis and Guillain-Barré syndrome.
Current opinion in neurology 1996;9(3):165-77.
1996: Gavin Giovannoni; J W Thorpe; D Kidd; B E Kendall; Ivan Moseley; Alan J Thompson; G Keir; David H Miller; M Feldmann; Edward J Thompson
Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease.
Journal of neurology, neurosurgery, and psychiatry 1996;60(1):20-6.